Measuring glucose concentrations in the rat brain using echo-time-averaged point resolved spectroscopy at 7 tesla

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Glucose is vital for brain function, but in vivo concentration estimation is challenging.
• Current methods like nuclear medicine only determine glucose uptake, not concentration.
• Magnetic resonance spectroscopy (MRS) offers potential but faces signal overlap issues.

Purpose of the Study:

• To develop and validate a method for accurate in vivo brain glucose concentration measurement using MRS.
• To overcome signal interference and T2 decay effects in glucose quantification.
• To assess the effectiveness of echo time (TE) averaging for precise glucose estimation.

Main Methods:

• Utilized echo time (TE) averaging between 60-95 ms to minimize interfering signals in MRS.
• Corrected for T2 signal loss in glucose concentration estimation and basis file creation.
• Measured brain glucose concentrations in fasted and fed rats to validate the TE-averaging method.

Main Results:

• The TE-averaging method yielded precise and consistent brain glucose estimates in rats.
• Fasted and fed rats showed distinct glucose-to-creatine ratios (0.15 ± 0.03 and 0.24 ± 0.04, respectively).
• Short TE measurements (13 ms) were unreliable, highlighting the benefit of TE averaging.

Conclusions:

• TE averaging effectively minimizes macromolecular signals and spectral overlap for accurate brain glucose quantification.
• This MRS technique provides reliable in vivo glucose measurements, crucial for understanding brain metabolism.
• The method demonstrates improved precision and consistency compared to short TE measurements.